Next Article in Journal
Smokefree Policies in Latin America and the Caribbean: Making Progress
Next Article in Special Issue
Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II Agents
Previous Article in Journal
Wars and Suicides in Israel, 1948–2006
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2012, 9(5), 1939-1953; doi:10.3390/ijerph9051939

The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome

1
Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina, 135 Dauer Drive, CB 7431, UNC, Chapel Hill, NC 27599, USA
2
Curriculum in Toxicology, The University of North Carolina, 135 Dauer Drive, CB 7431, UNC, Chapel Hill, NC 27599, USA
*
Author to whom correspondence should be addressed.
Received: 21 March 2012 / Revised: 27 April 2012 / Accepted: 8 May 2012 / Published: 18 May 2012
(This article belongs to the Special Issue Leukemia Arising from Chemical Exposures and Chemotherapeutic Drugs)
View Full-Text   |   Download PDF [429 KB, uploaded 19 June 2014]   |  

Abstract

Recent research has spotlighted the role of microRNAs (miRNAs) as critical epigenetic regulators of hematopoietic stem cell differentiation and leukemia development. Despite the recent advances in knowledge surrounding epigenetics and leukemia, the mechanisms underlying miRNAs’ influence on leukemia development have yet to be clearly elucidated. Our aim was to identify high ranking biological pathways altered at the gene expression level and under epigenetic control. Specifically, we set out to test the hypothesis that miRNAs dysregulated in acute myeloid leukemia (AML) converge on a common pathway that can influence signaling related to hematopoiesis and leukemia development. We identified genes altered in AML patients that are under common regulation of seven key miRNAs. By mapping these genes to a global interaction network, we identified the “AML Signalisome”. The AML Signalisome comprises 53 AML-associated molecules, and is enriched for proteins that play a role in the aryl hydrocarbon receptor (AhR) pathway, a major regulator of hematopoiesis. Furthermore, we show biological enrichment for hematopoiesis-related proteins within the AML Signalisome. These findings provide important insight into miRNA-regulated pathways in leukemia, and may help to prioritize targets for disease prevention and treatment. View Full-Text
Keywords: aryl hydrocarbon receptor; gene expression; leukemia; microRNA; systems biology aryl hydrocarbon receptor; gene expression; leukemia; microRNA; systems biology
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Rager, J.E.; Fry, R.C. The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome. Int. J. Environ. Res. Public Health 2012, 9, 1939-1953.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top